Primary resistance of hepatitis B virus to nucleoside and nucleotide analogues
Stephane CHEVALIEZ,
Christophe RODRIGUEZ,
Lila POITEAU,
Alexandre SOULIER,
F Donati,
Mélanie MERCIER-DARTY,
C Pioche,
V Leroy,
V Brodard,
F Zoulim,
C Brouard,
C Larsen,
C Semaille,
F Roudot-Thoraval,
Jean-Michel PAWLOTSKY,
Hepatology Reference Centers Laboratories Network for Chronic Hepatitis B Surveillance
J Viral Hepat 19/10/2018;- : - 10.1111/jvh.13025
Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016)
N Lydie,
L Saboni,
E Gautier,
C Brouard,
Stephane CHEVALIEZ,
F Barin,
C Larsen,
F Lot,
D Rahib,
JMIR Res Protoc. 12/10/2018;7(10) : e180 10.2196/resprot.9797.
12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation
P Houssel-Debry,
A Coilly,
C Fougerou-Leurent,
C Jezequel,
C Duvoux,
V De Ledinghen,
S Radenne,
N Kamar,
V Leroy,
V Di Martino,
L D'Alteroche,
V Canva,
F Conti,
J Dumortier,
H Montialoux,
P Lebray,
D Botta-Fridlund,
A Tran,
C Moreno,
C Silvain,
C Besch,
P Perre,
C Francoz,
A Abergel,
F Habersetzer,
M Debette-Gratien,
C Cagnot,
A Diallo,
Stephane CHEVALIEZ,
E Rossignol,
A Veislinger,
JC Duclos-Vallee,
GP Pageaux,
ANRS CO23 CUPILT study group.
Hepatology 01/10/2018;68(4) : 1277-1287 10.1002/hep.29918
The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania.
Z Mohamed,
J Rwegasha,
JU Kim,
Y Shimakawa,
Lila POITEAU,
Stephane CHEVALIEZ,
S Bhagani,
SD Taylor-Robinson,
MR Thursz,
J Mbwambo,
M Lemoine,
J Viral Hepat. 03/07/2018;- : - 10.1111/jvh.12966.
